Physical activity, multimorbidity, and life expectancy: a UK Biobank longitudinal study

被引:171
|
作者
Chudasama, Yogini V. [1 ,2 ]
Khunti, Kamlesh K. [1 ,2 ]
Zaccardi, Francesco [1 ]
Rowlands, Alex V. [1 ,3 ,4 ]
Yates, Thomas [1 ,3 ]
Gillies, Clare L. [1 ]
Davies, Melanie J. [1 ,3 ]
Dhalwani, Nafeesa N. [1 ,2 ,5 ]
机构
[1] Univ Leicester, Leicester Gen Hosp, Diabet Res Ctr, Leicester LE5 4PW, Leics, England
[2] Leicester Diabet Ctr, Collaborat Leadership Appl Hlth Res & Care East M, NIHR, Leicester LE5 4PW, Leics, England
[3] Leicester Diabet Ctr, NIHR Leicester Biomed Res Ctr, Leicester LE5 4PW, Leics, England
[4] Univ South Australia, Sansom Inst Hlth Res, Div Hlth Sci, ARENA, Adelaide, SA 5001, Australia
[5] Evidera, Real World Evidence, London W6 8BJ, England
关键词
Multimorbidity; Co-morbidity; Physical activity; Life expectancy; Mortality; UK Biobank; FLEXIBLE PARAMETRIC MODELS; HEALTH-CARE; MORTALITY; SURVIVAL;
D O I
10.1186/s12916-019-1339-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundMultimorbidity is an emerging public health priority. Physical activity (PA) is recommended as one of the main lifestyle behaviours, yet the benefits of PA for people with multimorbidity are unclear. We assessed the benefits of PA on mortality and life expectancy in people with and without multimorbidity.MethodsUsing the UK Biobank dataset, we extracted data on 36 chronic conditions and defined multimorbidity as (a) 2 or more conditions, (b) 2 or more conditions combined with self-reported overall health, and (c) 2 or more top-10 most common comorbidities. Leisure-time PA (LTPA) and total PA (TPA) were measured by questionnaire and categorised as low (<600 metabolic equivalent (MET)-min/week), moderate (600 to <3000 MET-min/week), and high (3000 MET-min/week), while objectively assessed PA was assessed by wrist-worn accelerometer and categorised as low (4min/day), moderate (10min/day), and high (22min/day) walking at brisk pace. Survival models were applied to calculate adjusted hazard ratios (HRs) and predict life expectancy differences.Results491,939 individuals (96,622 with 2 or more conditions) had a median follow-up of 7.0 (IQR 6.3-7.6) years. Compared to low LTPA, for participants with multimorbidity, HR for mortality was 0.75 (95% CI 0.70-0.80) and 0.65 (0.56-0.75) in moderate and high LTPA groups, respectively. This finding was consistent when using TPA measures. Using objective PA, HRs were 0.49 (0.29-0.80) and 0.29 (0.13-0.61) in the moderate and high PA groups, respectively. These findings were similar for participants without multimorbidity. In participants with multimorbidity, at the age of 45years, moderate and high LTPA were associated with an average of 3.12 (95% CI 2.53, 3.71) and 3.55 (2.34, 4.77) additional life years, respectively, compared to low LTPA; in participants without multimorbidity, corresponding figures were 1.95 (1.59, 2.31) and 1.85 (1.19, 2.50). Similar results were found with TPA. For objective PA, moderate and high levels were associated with 3.60 (-0.60, 7.79) and 5.32 (-0.47, 11.11) life years gained compared to low PA for those with multimorbidity and 3.88 (1.79, 6.00) and 4.51 (2.15, 6.88) life years gained in those without. Results were consistent when using other definitions of multimorbidity.ConclusionsThere was an inverse dose-response association between PA and mortality. A moderate exercise is associated with a longer life expectancy, also in individuals with multimorbidity.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] FRAILTY AND MULTIMORBIDITY IN TYPE 2 DIABETES: A UK BIOBANK ANALYSIS
    Hanlon, P.
    Jani, B. D.
    Butterly, E.
    Nicholl, B.
    Lewsey, J.
    McAllister, D. A.
    Mair, F. S.
    [J]. AGE AND AGEING, 2021, 50
  • [32] Associations between multimorbidity and adverse health outcomes in UK Biobank and the SAIL Databank: A comparison of longitudinal cohort studies
    Hanlon, Peter
    Jani, Bhautesh A.
    Nicholl, Barbara S.
    Lewsey, Jim
    McAllister, David
    Mair, Frances
    [J]. PLOS MEDICINE, 2022, 19 (03)
  • [33] Physical activity types and life expectancy with and without cardiovascular disease: the Rotterdam Study
    Dhana, Klodian
    Koolhaas, Chantal M.
    Berghout, Mathilde A.
    Peeters, Anna
    Ikram, M. Arfan
    Tiemeier, Henning
    Hofman, Albert
    Nusselder, Wilma
    Franco, Oscar H.
    [J]. JOURNAL OF PUBLIC HEALTH, 2017, 39 (04) : E209 - E218
  • [34] Physical activity and cancer risk: Findings from the UK Biobank, a large prospective cohort study
    Murray, Jennifer M.
    Coleman, Helen G.
    Hunter, Ruth F.
    [J]. CANCER EPIDEMIOLOGY, 2020, 68
  • [35] Socioecological approach for identifying the determinants of objectively measured physical activity: A prospective study of the UK Biobank
    Choi, Jaesung
    Park, JooYong
    Kim, Ji-Eun
    Kang, Daehee
    Cho, Sung-il
    Chung, Ick-Joong
    Shin, Aesun
    Lee, Miyoung
    Choi, Ji-Yeob
    [J]. PREVENTIVE MEDICINE, 2022, 155
  • [36] Physical activity and left ventricular trabeculation in the UK Biobank community-based cohort study
    Woodbridge, Simon P.
    Aung, Nay
    Paiva, Jose M.
    Sanghvi, Mihir M.
    Zemrak, Filip
    Fung, Kenneth
    Petersen, Steffen E.
    [J]. HEART, 2019, 105 (13) : 990 - +
  • [37] Diet, Physical Activity, and Disinhibition in Middle-Aged and Older Adults: A UK Biobank Study
    Schweren, Lizanne J. S.
    van Rooij, Daan
    Shi, Huiqing
    Larsson, Henrik
    Arias-Vasquez, Alejandro
    Li, Lin
    Grimstvedt Kvalvik, Liv
    Haavik, Jan
    Buitelaar, Jan
    Hartman, Catharina
    [J]. NUTRIENTS, 2021, 13 (05)
  • [38] Association of Time-of-Day Physical Activity With Incident Cardiovascular Disease: The UK Biobank Study
    Ma, Tongyu
    Sirard, John R.
    Jennings, Lydia
    [J]. JOURNAL OF PHYSICAL ACTIVITY & HEALTH, 2023, 20 (06): : 547 - 554
  • [39] Physical Activity and Mortality Across Levels of Adiposity: A Prospective Cohort Study From the UK Biobank
    Sanchez-Lastra, Miguel A.
    Ding, Ding
    Dalene, Knut-Eirik
    Ekelund, Ulf
    Tarp, Jakob
    [J]. MAYO CLINIC PROCEEDINGS, 2021, 96 (01) : 105 - 119
  • [40] Physical activity and life expectancy with and without diabetes - Life table analysis of the Framingham heart study
    Jonker, JT
    De Laet, C
    Franco, OH
    Peeters, A
    Mackenbach, J
    Nusselder, WJ
    [J]. DIABETES CARE, 2006, 29 (01) : 38 - 43